Racial and ethnic disparities in the receipt of cancer treatment
- PMID: 11880473
- DOI: 10.1093/jnci/94.5.334
Racial and ethnic disparities in the receipt of cancer treatment
Abstract
A disproportionate number of cancer deaths occur among racial/ethnic minorities, particularly African Americans, who have a 33% higher risk of dying of cancer than whites. Although differences in incidence and stage of disease at diagnosis may contribute to racial disparities in mortality, evidence of racial disparities in the receipt of treatment of other chronic diseases raises questions about the possible role of inequities in the receipt of cancer treatment. To evaluate racial/ethnic disparities in the receipt of cancer treatment, we examined the published literature that addressed access/use of specific cancer treatment procedures, trends in patterns of use, or survival studies. We found evidence of racial disparities in receipt of definitive primary therapy, conservative therapy, and adjuvant therapy. These treatment differences could not be completely explained by racial/ethnic variation in clinically relevant factors. In many studies, these treatment differences were associated with an adverse impact on the health outcomes of racial/ethnic minorities, including more frequent recurrence, shorter disease-free survival, and higher mortality. Reducing the influence of nonclinical factors on the receipt of cancer treatment may, therefore, provide an important means of reducing racial/ethnic disparities in health. New data resources and improved study methodology are needed to better identify and quantify the full spectrum of nonclinical factors that contribute to the higher cancer mortality among racial/ethnic minorities and to develop strategies to facilitate receipt of appropriate cancer care for all patients.
Similar articles
-
Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) Program population-based study.Arch Intern Med. 2002 Sep 23;162(17):1985-93. doi: 10.1001/archinte.162.17.1985. Arch Intern Med. 2002. PMID: 12230422
-
Geographic variations of racial/ethnic disparities in cervical cancer mortality in Texas.South Med J. 2014 May;107(5):281-8. doi: 10.1097/SMJ.0000000000000100. South Med J. 2014. PMID: 24937725
-
Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.J Natl Cancer Inst. 2009 Jul 15;101(14):984-92. doi: 10.1093/jnci/djp175. Epub 2009 Jul 7. J Natl Cancer Inst. 2009. PMID: 19584328 Free PMC article.
-
Racial/ethnic disparities in breast and gynecologic cancer treatment and outcomes.Curr Opin Obstet Gynecol. 2007 Feb;19(1):31-6. doi: 10.1097/GCO.0b013e3280117cf8. Curr Opin Obstet Gynecol. 2007. PMID: 17218849 Review.
-
Prostate cancer in black and white Americans.Cancer Metastasis Rev. 2003 Mar;22(1):83-6. doi: 10.1023/a:1022216119066. Cancer Metastasis Rev. 2003. PMID: 12716039 Review.
Cited by
-
Barriers to cancer treatment for people experiencing socioeconomic disadvantage in high-income countries: a scoping review.BMC Health Serv Res. 2024 May 28;24(1):670. doi: 10.1186/s12913-024-11129-2. BMC Health Serv Res. 2024. PMID: 38807237 Free PMC article. Review.
-
Area Vulnerability and Disparities in Therapy for Patients With Metastatic Renal Cell Carcinoma.JAMA Netw Open. 2024 Apr 1;7(4):e248747. doi: 10.1001/jamanetworkopen.2024.8747. JAMA Netw Open. 2024. PMID: 38687479 Free PMC article.
-
Systematic analysis of off-label and off-guideline cancer therapy usage in a real-world cohort of 165,912 US patients.Cell Rep Med. 2024 Mar 19;5(3):101444. doi: 10.1016/j.xcrm.2024.101444. Epub 2024 Feb 29. Cell Rep Med. 2024. PMID: 38428426 Free PMC article.
-
Trends in gynaecologic cancer mortality and the impact of the COVID-19 pandemic in the United States.Infect Agent Cancer. 2024 Feb 20;19(1):4. doi: 10.1186/s13027-024-00567-6. Infect Agent Cancer. 2024. PMID: 38378712 Free PMC article.
-
Ethnic disparities in the incidence of gynecologic malignancies among Israeli Women of Arab and Jewish Ethnicity: a 10-year study (2010-2019).Ther Adv Reprod Health. 2023 Dec 30;18:26334941231209496. doi: 10.1177/26334941231209496. eCollection 2024 Jan-Dec. Ther Adv Reprod Health. 2023. PMID: 38164343 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical